Spring til hovednavigatio
Spring til søgning
Spring til hovedindhold
Sorter
Medicine and Dentistry
Magnetic Resonance Imaging
100%
Placenta
72%
Positron Emission Tomography-Computed Tomography
47%
Diffusion MRI
47%
Placenta Disorder
47%
Gallium 68
35%
Birth Weight
35%
Prostate Cancer
33%
Transitional Cell Carcinoma
32%
Biological Marker
31%
Fetus Growth
30%
Exome Sequencing
28%
Gestational Age
26%
Comorbidity
24%
Non Muscle Invasive Bladder Cancer
23%
Granulosa Cell Tumour
23%
Kidney Cancer
23%
Severe Acute Respiratory Syndrome Coronavirus 2
23%
Computed Tomography Angiography
23%
Cohort Analysis
23%
Blood-Oxygen-Level Dependent
23%
Kidney Metastasis
23%
Pulsatility Index
22%
Histology
22%
Muscle Invasive Bladder Cancer
20%
Overall Survival
20%
Neoplasm
19%
Carcinoma in Situ
18%
Immunotherapy
18%
Uterine Artery
18%
High Risk Population
17%
Infection
17%
Stillbirth
16%
Fetal Membrane
15%
Low Birth Weight
15%
Premature Labor
15%
Lymph Node
15%
Cystectomy
15%
Bladder Cancer
15%
Preterm Delivery
15%
Metastatic Carcinoma
15%
Newborn Death
14%
Hazard Ratio
14%
Tumor
14%
Renal Agenesis
14%
Placenta Function
14%
COVID-19
13%
Regression Analysis
12%
Elderly Patient
11%
Biglycan
11%
Keyphrases
Non-muscle Invasive Bladder Cancer (NMIBC)
37%
Diffusion Magnetic Resonance Imaging (dMRI)
35%
Prostate Cancer
29%
Renal Cancer
23%
National Cohort Study
23%
68Ga-PSMA PET
23%
Normal Pregnancy
23%
Tumor
20%
Birth Weight
20%
Placental Dysfunction
18%
Placenta
17%
Comorbidity
16%
Vascular Malperfusion
15%
Molecular Subtypes
14%
Placental Pathology
14%
Metastasis
14%
Newly Diagnosed
13%
Positron Emission Tomography/computed Tomography (PET/CT)
13%
Histological Examination
13%
Placental MRI
13%
Overall Survival
12%
Metastatic Renal Cell Carcinoma (mRCC)
11%
Urothelial Bladder Cancer
11%
Transurethral Surgery
11%
Urothelial Cancer
11%
Renal Cell Carcinoma
11%
Urachus
11%
MRI Diffusion
11%
Bladder Wall
11%
Primary Mediastinal Choriocarcinoma
11%
Choriocarcinoma
11%
Goserelin
11%
Weight Comparison
11%
ISUP Grade
11%
Uterine Artery Pulsatility Index
11%
Fetoplacental
11%
Diabetes Mellitus
11%
Sex Chromosome Aneuploidy
11%
Diagnostic Test Accuracy
11%
National Survival
11%
T2 Measurements
11%
Multi-omics Analysis
11%
Clinical Consequences
11%
Definitive Chemoradiotherapy (dCRT)
11%
18F-FDG PET-CT
11%
CT-like MRI
11%
Motion Analysis
11%
Computed Tomography Angiography
11%
Bladder
11%
Lymph Node Staging
11%
